What is the best time of day to take Wegovy?

Wegovy (semaglutide) is injected once weekly, not daily — so the question is really about which day and time fits your routine best, not morning versus evening in isolation.
Clinical guidance does not specify a required time of day; consistency across weeks matters more than the clock.
Some people time their injection to manage nausea around meals, rest, or lighter schedule days, a strategy worth discussing with your prescriber.
Changing your injection day is possible, but the gap between doses must never fall below four days, any adjustment should be agreed with your prescriber first.

There is no single time of day that clinical guidance mandates for Wegovy injections. The semaglutide SmPC and NHS guidance confirm that Wegovy's once-weekly dose can be taken at any time of day, with or without food — the most important thing is picking a day and time you can stick to consistently each week. That said, many people do find certain times work better in practice, and the reasoning is worth understanding before you settle on a routine.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How timing, routine and side-effect management interact in practice

What the trial evidence and prescribing guidance actually say about timing

The STEP 1 trial, which studied semaglutide 2.4mg over 68 weeks and is one of the key studies behind Wegovy's UK licence, placed no restriction on injection time. Participants injected once weekly at whatever time suited them. The NHS medicines page for semaglutide reflects this: it notes that Wegovy can be taken at any time of day, with or without food, and that the priority is choosing a regular weekly schedule you can maintain.

That evidence base is worth stating plainly, because a common belief circulates that morning injections are medically required or produce better results. There is no published UK clinical data supporting that claim. The consistency of the weekly interval (not the hour of the day) is what the prescribing guidance emphasises.

For people who want a deeper look at whether there is a best time of day to take Wegovy based on individual circumstances, the short answer from the evidence is: the best time is whichever one you will actually keep week after week, and our guide on what time of day works best for taking Wegovy walks through the practical considerations in more detail. Skipping or significantly delaying a dose has a more meaningful effect on outcomes than shifting your window by a few hours.

The Wegovy Patient Information Leaflet, available via the Wegovy SmPC on the eMC, includes the full prescribing detail. Our prescribers review it alongside your individual health picture before approving any treatment.

How nausea patterns can inform when you inject

Nausea is the side effect most likely to shape your timing choice. It is the most commonly reported gastrointestinal effect in the STEP 1 trial data, typically peaking in the first day or two after injection before settling. It usually eases as the weeks progress, and tends to be more noticeable at the start of treatment or after a dose increase.

Because of this, many people choose to inject on a day when they have a lighter schedule the following day: a Friday evening injection, for example, means any initial discomfort falls over the weekend rather than a busy workday. Others prefer a morning injection so that any nausea is at its worst during daylight hours when they feel more able to manage it, rather than disturbing sleep.

Neither approach is clinically superior. Both reflect sensible personal planning. If nausea is a concern, choosing the right time to start Wegovy is part of the same conversation, one worth raising at consultation rather than after the first pen has arrived.

Our prescribers hear this question regularly. The practical advice they give most often is to avoid injecting immediately before a large meal, since slowed gastric emptying can intensify discomfort in the early weeks. A small snack or a longer gap before eating tends to help.

Picking a day and sticking to it: what flexibility you actually have

Wegovy is a once-weekly injection, so the question of timing is less about AM versus PM and more about which day of the week anchors your routine. Pairing the injection with something already fixed (a Sunday morning after breakfast, a Monday evening before a walk) makes it far less likely to slip.

The SmPC confirms you can change your injection day if needed, provided at least four days separate the previous dose from the new one. Once the new day is established, continue from there. A prescriber should confirm any planned change, particularly during the dose-escalation period when consistency is most relevant.

People who are transferring from the standard 2.4mg Wegovy dose or moving onto the newer 7.2mg presentation will find that the same weekly-consistency principle applies regardless of dose. If you are considering treatment options more broadly, our Wegovy treatment page covers the licensed schedule and what to expect at each stage. For a broader comparison with other semaglutide-based options, timing guidance for semaglutide for weight loss follows the same core logic.

Where to go from here if you are considering Wegovy

Wegovy is a prescription-only medicine. A prescriber (not an algorithm) reviews every consultation at nume before any treatment is issued. Practical questions like injection timing, managing early side effects, and adjusting your schedule if life gets in the way are all part of that ongoing clinical relationship, not afterthoughts.

If you are weighing up costs as part of your decision, our Wegovy price page sets out what a legitimate private prescription includes and what the market context looks like. For a broader look at how Wegovy compares to other weight-loss treatment options, that page covers the licensed landscape.

When you are ready to talk through eligibility and whether Wegovy suits your circumstances, our prescribers are available the same day. Check your eligibility with a free consultation, there are no fees unless treatment is right for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions